Fekete, B.; Biró, K.; Gyergyay, F.; Polk, N.; Horváth, O.; Géczi, L.; Patócs, A.; Budai, B.
Prediction of PSA Response after Dexamethasone Switch during Abiraterone Acetate + Prednisolone Treatment of Metastatic Castration-Resistant Prostate Cancer Patients. Cancers 2024, 16, 2760.
https://doi.org/10.3390/cancers16152760
AMA Style
Fekete B, Biró K, Gyergyay F, Polk N, Horváth O, Géczi L, Patócs A, Budai B.
Prediction of PSA Response after Dexamethasone Switch during Abiraterone Acetate + Prednisolone Treatment of Metastatic Castration-Resistant Prostate Cancer Patients. Cancers. 2024; 16(15):2760.
https://doi.org/10.3390/cancers16152760
Chicago/Turabian Style
Fekete, Bertalan, Krisztina Biró, Fruzsina Gyergyay, Nándor Polk, Orsolya Horváth, Lajos Géczi, Attila Patócs, and Barna Budai.
2024. "Prediction of PSA Response after Dexamethasone Switch during Abiraterone Acetate + Prednisolone Treatment of Metastatic Castration-Resistant Prostate Cancer Patients" Cancers 16, no. 15: 2760.
https://doi.org/10.3390/cancers16152760
APA Style
Fekete, B., Biró, K., Gyergyay, F., Polk, N., Horváth, O., Géczi, L., Patócs, A., & Budai, B.
(2024). Prediction of PSA Response after Dexamethasone Switch during Abiraterone Acetate + Prednisolone Treatment of Metastatic Castration-Resistant Prostate Cancer Patients. Cancers, 16(15), 2760.
https://doi.org/10.3390/cancers16152760
